Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology - Basic: Basic Science

  • You have access
    188Re Dose escalation in tumored mice by MORF/cMORF pretargeting
    Guozheng Liu, Shuping Dou, Ali Akalin, Dengfeng Cheng, Ling Chen, Mary Rusckowski and Donald Hnatowich
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1565;
  • You have access
    PET response evaluation to tyrosine kinase inhibitors in a GIST xenograft model
    Mona-Elisabeth Revheim, Kathrine Roe, Tore Bach-Gansmo, Arne Skretting, Bodil Bjerkehagen, Jeanne-Marie Berner and Therese Seierstad
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1583;
  • You have access
    Dicer substrate siRNA-mediated silencing of human sodium iodide symporter (hNIS) gene in hNIS-expressing cell lines
    So Yeon Pakr and Won Woo Lee
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1591;
  • You have access
    Small animal PET imaging of recombinant single chain fragment variable of anti-TAG-72 humanized antibody in colon cancer xenograft model
    JJ Son, JH Jung, TS Lee, SK Woo, KI Ahn, HJ Hong, YS Park, CW Choi and SM Lim
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1592;
  • You have access
    Enhancing anti-CD20 directed radioimmunotherapy. Preliminary studies using lenalidomide-accelerated internalization
    NG Schaefer, R Balasubramanian, H Song, J Engles and R Wahl
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1609;
  • You have access
    Hypoxia imaging agent 64Cu-ATSM visualizes cancer stem cell-rich regions within tumors
    Yukie Yoshii, Yasushi Kiyono, Atsuo Waki, Tetsuya Mori, Hiroshi Yoshii, Takako Furukawa, Myungmi Oh, Masato Kobayashi, Michael J. Welch and Yasuhisa Fujibayashi
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1554;
  • You have access
    PET radioimmunodetection of neuroblastoma: Optimizing pharmacokinetics through antibody engineering
    Jason Dearling, Stephan Voss, Patricia Dunning, Erin Snay, Frederick Fahey, Ted Treves and Alan Packard
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1556;
  • You have access
    99mTc-Annexin-V and 99mTc-Sestamibi uptake as indicators of chemotherapy induced apoptosis.
    Paola Anna Erba, Enrica Tusi, Chiara Manfredi, Maria Teresa Locci, Martina Sollini, Elena Lazzeri, Katrin Massri, Luisa Locantore and Giuliano Mariani
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1575;
  • You have access
    Sorafenib efficacy in lymphoma pre-clinical models
    Valentina Ambrosini, Carmelo Quarta, Pier Luigi Zinzani, Cristina Nanni, Milena Fini, Paola Torricelli, Gianluca Giavaresi, Antonia D'Errico, Deborah Malvi and Stefano Fanti
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1553;
  • You have access
    PET (18F-FDG) and SPECT (99mTc-1) agents in preclinical models of melanoma metastasis in mice
    Naengnoi Limpa-Amara, Robert Zimmerman, Alun Jones and Ashfaq Mahmood
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1603;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire